Page last updated: 2024-10-18

dalteparin and Infection

dalteparin has been researched along with Infection in 4 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

Excerpt	Relevance	Reference
"Venous thromboembolism was previously regarded as a surgical problem, but occurs at least as frequently among medical patients."	1.32	Venous thromboembolic risk and prevention in acute medical illness. ( Hampton, KK, 2003)

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kakkar, AK	1
Cimminiello, C	1
Goldhaber, SZ	1
Parakh, R	1
Wang, C	1
Bergmann, JF	2
Cohen, AT	1
Mouly, S	1
Hampton, KK	1

Clinical Trials (2)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
International, Multi-center, Randomized, Double Blind Study to Compare the Overall Mortality in Acutely Ill Medical Patients Treated With Enoxaparin Versus Placebo in Addition to Graduated Elastic Stockings[NCT00622648]	Phase 4	8,329 participants (Actual)	Interventional	2008-01-31	Completed
Title: EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients[NCT03243708]		90,537 participants (Actual)	Interventional	2017-12-04	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for dalteparin and Infection

Article	Year
Discoveries in thrombosis care for medical patients. Seminars in thrombosis and hemostasis, 2002, Volume: 28 Suppl 3 Topics: Clinical Trials as Topic; Cost-Benefit Analysis; Critical Care; Drug Costs; Enoxaparin; Fibrinolytic	2002
Thromboprophylaxis in medical patients: focus on France. Seminars in thrombosis and hemostasis, 2002, Volume: 28 Suppl 3 Topics: Acute Disease; Adult; Aged; Attitude of Health Personnel; Cardiovascular Diseases; Double-Blind Meth	2002

Trials

1 trial available for dalteparin and Infection

Article	Year
Low-molecular-weight heparin and mortality in acutely ill medical patients. The New England journal of medicine, 2011, Dec-29, Volume: 365, Issue:26 Topics: Acute Disease; Aged; Anticoagulants; Cause of Death; Combined Modality Therapy; Double-Blind Method;	2011
Low-molecular-weight heparin and mortality in acutely ill medical patients. The New England journal of medicine, 2011, Dec-29, Volume: 365, Issue:26 Topics: Acute Disease; Aged; Anticoagulants; Cause of Death; Combined Modality Therapy; Double-Blind Method;	2011
Low-molecular-weight heparin and mortality in acutely ill medical patients. The New England journal of medicine, 2011, Dec-29, Volume: 365, Issue:26 Topics: Acute Disease; Aged; Anticoagulants; Cause of Death; Combined Modality Therapy; Double-Blind Method;	2011
Low-molecular-weight heparin and mortality in acutely ill medical patients. The New England journal of medicine, 2011, Dec-29, Volume: 365, Issue:26 Topics: Acute Disease; Aged; Anticoagulants; Cause of Death; Combined Modality Therapy; Double-Blind Method;	2011

Other Studies

1 other study available for dalteparin and Infection

Article	Year
Venous thromboembolic risk and prevention in acute medical illness. International journal of clinical practice, 2003, Volume: 57, Issue:5 Topics: Acute Disease; Aged; Anticoagulants; Cardiac Output, Low; Enoxaparin; Female; Hospitalization; Human	2003